Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T84726 | Target Info | |||
Target Name | Rho-associated protein kinase (ROCK) | ||||
Synonyms |
Rho-associated, coiled-coil-containing protein kinase; Rho associated protein kinase
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | NO-GeName | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Clinical trial Target | ||||
UniProt ID | AKT1_HUMAN | |||||
Gene Name | AKT1 | |||||
Synonyms |
RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; PKB alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | AT13148 | Drug Info | IC50 = 38 nM | [1] | ||
Co-Target Name | RAC-gamma serine/threonine-protein kinase (AKT3) | Clinical trial Target | ||||
UniProt ID | AKT3_HUMAN | |||||
Gene Name | AKT3 | |||||
Synonyms |
STK-2; RAC-PK-gamma; Protein kinase B gamma; Protein kinase Akt-3; PKBG; PKB gamma
Click to Show/Hide
|
|||||
Representative Drug(s) | AT13148 | Drug Info | IC50 = 50 nM | [1] | ||
Co-Target Name | HUMAN protein kinase cAMP-activated catalytic subunit alpha (PRKACA) | Literature-reported Target | ||||
UniProt ID | KAPCA_HUMAN | |||||
Gene Name | PRKACA | |||||
Synonyms |
PKA C-alpha; cAMP-dependent protein kinase catalytic subunit alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | AT13148 | Drug Info | IC50 < 10 nM | [1] | ||
Co-Target Name | RAC-beta serine/threonine-protein kinase (AKT2) | Literature-reported Target | ||||
UniProt ID | AKT2_HUMAN | |||||
Gene Name | AKT2 | |||||
Synonyms |
RAC-PK-beta; Protein kinase B beta; Protein kinase Akt-2; PKB beta
Click to Show/Hide
|
|||||
Representative Drug(s) | AT13148 | Drug Info | IC50 = 402 nM | [1] | ||
Co-Target Name | Protein kinase N2 (PKN2) | Literature-reported Target | ||||
UniProt ID | PKN2_HUMAN | |||||
Gene Name | PKN2 | |||||
Synonyms |
Serine/threonine-protein kinase N2; Protein-kinase C-related kinase 2; Protein kinase C-like 2; PRKCL2; PRK2; PKN gamma
Click to Show/Hide
|
|||||
Representative Drug(s) | Ximelegatran | Drug Info | IC50 = 600 nM | [2] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Recent progress towards clinically relevant ATP-competitive Akt inhibitors. Bioorg Med Chem Lett. 2017 Jul 1;27(13):2838-48. | ||||
REF 2 | Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000 Oct 1;351(Pt 1):95-105. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.